Blog Archives

Acute effects of passive leg cycling on upper extremity tremor and bradykinesia in Parkinson’s disease

A. Ridgel, M. Muller, C. Kim, E. Fickes, T. Mera
Phys Sportsmed. 2011 Sep;39(3):83-93

Read more ›



PRESS RELEASE: The University of Rochester and Great Lakes NeuroTechnologies launch new clinical study to develop ambulatory dyskinesia assessment system

VIEW PRESS RELEASE [PDF]

Cleveland, OH – August 15, 2011 – Great Lakes NeuroTechnologies’ KinetiSense motion sensor technology will be used in a clinical study to capture and quantify dyskinesias (involuntary, irregular movements) caused by Parkinson’s disease (PD) medication. PD motor symptoms including tremor and bradykinesia are typically treated with levodopa.

Read more ›



PRESS RELEASE: Great Lakes NeuroTechnologies’ KinetiSense technology used in Parkinson’s disease gait and balance study

VIEW PRESS RELEASE [PDF]

Cleveland, OH – August 15, 2011 – Great Lakes NeuroTechnologies’ KinetiSense motion sensor technology was used in a clinical study to capture and quantify the effect of Deep Brain Stimulation (DBS) on gait and balance impairment in Parkinson’s disease (PD).

Read more ›



Differential Response of Bradykinesia and Hypokinesia to Levodopa in Parkinson’s Disease

A. Espay, J. Giuffrida, Robert Chen, Jennifer E. Vaughan, Andrew P. Duker, D. Heldman
Presented at the 2009 World Federation of Neurology World Congress on Parkinson’s Disease and Related Disorders

Read more ›



PRESS RELEASE: CLEVEMED LAUNCHES CLINICIAL STUDY MONITORING PARKINSON’S DISEASE MOTOR SYMPTOMS IN THE CLINIC AND AT HOME USING KINESIA™

VIEW PRESS RELEASE [PDF]

CLEVELAND, Ohio (January 28, 2009) – Cleveland Medical Devices Inc. (CleveMed) has launched a large scale multicenter clinical study to continue development and validation of Kinesia™, a compact wireless system for monitoring severity of Parkinson’s disease (PD) motor symptoms. Kinesia uses miniature motion sensors worn on the hand and wirelessly transmits motor symptom information to a PC.

Read more ›



PRESS RELEASE: CLEVEMED RECEIVES $1.23 MILLION IN NIH FUNDING TO DEVELOP A SYSTEM TO AUGMENT DEEP BRAIN STIMULATION PROGRAMMING IN PARKINSON´S DISEASE

VIEW PRESS RELEASE [PDF]

CLEVELAND, OHIO, OCT 7, 2008 – Cleveland Medical Devices Inc. (CleveMed) announced it has been awarded $1.23 million in NIH SBIR FastTrack funding from the National Institute on Aging to develop ParkinTune™, a system to augment stimulator programming in deep brain stimulation (DBS) procedures for Parkinson´s disease (PD).

Read more ›



Comparison of Kinesia to the Unified Parkinson’s Disease Rating Scale: Tremor and Bradykinesia Results

D. Heldman, Ph.D., David E. Riley, M.D., Brian N. Maddux, M.D., Ph.D.,J. Giuffrida, Ph.D.
Presented at the 2008 American Academy of Neurology Annual Meeting

Read more ›



PRESS RELEASE: FROST & SULLIVAN LAUDS CLEVEMED FOR KINESIA™, A REVOLUTIONARY MOBILITY DISORDER MONITORING SYSTEM

VIEW PRESS RELEASE [PDF]

Palo Alto, Calif. – March 12, 2008 – Based on its recent analysis of the mobility disorder monitoring systems market, Frost & Sullivan recognizes Cleveland Medical Devices Inc. (CleveMed) with the 2008 North American Product Innovation of the Year Award.

Read more ›



Top